News-Medical.Net on MSN7h
Adding curcumin boosts the efficacy of bedaquiline in combating M. abscessus infections
Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...
STAT16h
Banning direct-to-consumer drug ads won’t work
But if we can’t ban pharmaceutical ads, we can at least rein them in. Policymakers can play an integral role in addressing the manipulative advertising practices rampant in the industry, while still ...
Devdiscourse8h
Breakthrough innovations in drug delivery: How advanced materials are shaping future of medicine
The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...
Clinical Trials Arena on MSN12h
AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic ...
Medscape1d
Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
GlobalData on MSN1d
Scholar Rock SMA drug shows muscle function benefit
Scholar Rock’s spinal muscular atrophy (SMA) therapy has shown benefit in muscle function in children under 12 in a pivotal ...
CNET on MSN11d
Natural Medicine vs. FDA Drugs: Which Should You Use for Your Ailment?
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
EurekAlert!8d
Next-gen drug testing: automated zebrafish screening system for precise cardiac toxicity assessment
A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...
Devdiscourse9d
AI-powered drug repurposing: A game changer for cancer research
The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.
Healio1d
Two-drug combination noninferior to current suppressive HIV therapy
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or ...